Literature DB >> 3024831

Synthesis of 5-amino-5-deoxy-D-galactopyranose and 1,5-dideoxy-1,5-imino-D-galactitol, and their inhibition of alpha- and beta-D-galactosidases.

G Legler, S Pohl.   

Abstract

A 12-step route is presented starting from 1,2:5,6-di-O-isopropylidene-alpha-D-glucofuranose for the preparation of the title compounds and their L-altro analogues. Their synthesis is based on the reduction with Raney nickel of a protected 5-hydroxyimino derivative of L-arabino-hexofuranos-5-ulose, with the following improvements for the preparation of a D-galactofuranose derivative: oxidation at C-3 with pyridinium dichromate-acetic anhydride, stereospecific reduction of a 3-O-acetyl-hex-3-enofuranose intermediate to the D-gulo derivative, and inversion at C-3 of its 3-tosylate with tetrabutylammonium acetate in chlorobenzene. alpha-D-Galactosidase from coffee beans and from Escherichia coli and beta-D-galactosidase from E. coli and Aspergillus wentii were inhibited with Ki values that ranged from 0.0007 to 8.2 microM. Formation of the enzyme-inhibitor complexes with the D-galactose analogue was on the time-scale of minutes, whereas the D-galactitol analogue showed a slow approach to the inhibition only with alpha-D-galactosidase from coffee beans and beta-D-galactosidase from A. wentii. N-Alkylation of the D-galactitol analogue was detrimental to the inhibition except for beta-D-galactosidase from E. coli and beta-D-glucosidase from almonds, but, even with these enzymes, the observed affinity enhancements were 10(2) to 10(3)-times smaller than those of N-alkylated D-galactosylamine and D-glucosylamine.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3024831     DOI: 10.1016/s0008-6215(00)90138-1

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  8 in total

1.  Enhanced endothelial delivery and biochemical effects of α-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease.

Authors:  Janet Hsu; Daniel Serrano; Tridib Bhowmick; Kishan Kumar; Yang Shen; Yuan Chia Kuo; Carmen Garnacho; Silvia Muro
Journal:  J Control Release       Date:  2010-11-01       Impact factor: 9.776

2.  Inhibition of the alpha-L-arabinofuranosidase III of Monilinia fructigena by 1,4-dideoxy-1,4-imino-L-threitol and 1,4-dideoxy-1,4-imino-L-arabinitol.

Authors:  M T Axamawaty; G W Fleet; K A Hannah; S K Namgoong; M L Sinnott
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

3.  The molecular basis of pharmacological chaperoning in human α-galactosidase.

Authors:  Abigail I Guce; Nathaniel E Clark; Jerome J Rogich; Scott C Garman
Journal:  Chem Biol       Date:  2011-12-23

4.  Synthesis of lipophilic 1-deoxygalactonojirimycin derivatives as D-galactosidase inhibitors.

Authors:  Georg Schitter; Elisabeth Scheucher; Andreas J Steiner; Arnold E Stütz; Martin Thonhofer; Chris A Tarling; Stephen G Withers; Jacqueline Wicki; Katrin Fantur; Eduard Paschke; Don J Mahuran; Brigitte A Rigat; Michael Tropak; Tanja M Wrodnigg
Journal:  Beilstein J Org Chem       Date:  2010-03-01       Impact factor: 2.883

5.  Planteose as a storage carbohydrate required for early stage of germination of Orobanche minor and its metabolism as a possible target for selective control.

Authors:  Takatoshi Wakabayashi; Benesh Joseph; Shuhei Yasumoto; Tomoyoshi Akashi; Toshio Aoki; Kazuo Harada; Satoru Muranaka; Takeshi Bamba; Eiichiro Fukusaki; Yasutomo Takeuchi; Koichi Yoneyama; Toshiya Muranaka; Yukihiro Sugimoto; Atsushi Okazawa
Journal:  J Exp Bot       Date:  2015-03-28       Impact factor: 6.992

Review 6.  Fabry Disease: Molecular Basis, Pathophysiology, Diagnostics and Potential Therapeutic Directions.

Authors:  Ken Kok; Kimberley C Zwiers; Rolf G Boot; Hermen S Overkleeft; Johannes M F G Aerts; Marta Artola
Journal:  Biomolecules       Date:  2021-02-12

7.  New α-galactosidase-inhibiting aminohydroxycyclopentanes.

Authors:  Patrick Weber; Roland Fischer; Seyed A Nasseri; Arnold E Stütz; Martin Thonhofer; Stephen G Withers; Andreas Wolfsgruber; Tanja M Wrodnigg
Journal:  RSC Adv       Date:  2021-04-29       Impact factor: 4.036

Review 8.  Pharmacological Chaperones: A Therapeutic Approach for Diseases Caused by Destabilizing Missense Mutations.

Authors:  Ludovica Liguori; Maria Monticelli; Mariateresa Allocca; Bruno Hay Mele; Jan Lukas; Maria Vittoria Cubellis; Giuseppina Andreotti
Journal:  Int J Mol Sci       Date:  2020-01-13       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.